NCT06467981Completed
Study of the Indications for Amyloid Positon Emission Tomography (PET) Scans and Their Usefulness for Patients With Suspected Alzheimer's Disease (AD)
Study of the Indications for Amyloid PET Scans and Their Usefulness in the Management of Patients With Suspected Alzheimer's Disease (AD)
Source: ClinicalTrials.gov · Last updated 5 Jun 2025
Brief summary (registry, in English)
The recent clinical authorization of amyloid Positon Emission Tomography (PET) in France represents a crucial step for the nuclear medicine community involved in the diagnosis of Alzheimer's disease (AD).
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 160 (actual)
- First submitted
- 11 Jun 2024
- Start date
- 1 Nov 2024
- Primary completion date
- 30 Dec 2024
- Lead sponsor
- Central Hospital, Nancy, France
- Diseases
- Alzheimer disease
- NCT number
- NCT06467981
What you commit to
- Study type: Observational
- Participants enrolled: 160
- From 1 Nov 2024 to the primary completion date, 30 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patient opposition to the use of their data for this research
Who the study is looking for
- Patients aged = or \> 18 years
- Patients who have had an amyloid PET scan with a PET request form including the indications for the examination
- Patient informed via a newsletter and non-opposition to the use of their data for research purposes (research objectives clearly explained in the letters)
Age in the registry: 18 years to 99 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Nuclear medicine department Coordinator of this site? Confirm its status | Vandœuvre-lès-Nancy | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.